nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Parkinson's disease—Hyoscyamine—pancreatitis	0.614	1	CpDpCtD
Pramipexole—HTR2A—pancreatitis	0.21	1	CbGaD
Pramipexole—Left ventricular failure—Hyoscyamine—pancreatitis	0.00448	0.0434	CcSEcCtD
Pramipexole—Myopia—Hyoscyamine—pancreatitis	0.00337	0.0326	CcSEcCtD
Pramipexole—Atrial arrhythmia—Hyoscyamine—pancreatitis	0.00265	0.0257	CcSEcCtD
Pramipexole—Accommodation disorder—Propantheline—pancreatitis	0.0025	0.0242	CcSEcCtD
Pramipexole—Tachypnoea—Hyoscyamine—pancreatitis	0.00215	0.0209	CcSEcCtD
Pramipexole—Supraventricular extrasystoles—Hyoscyamine—pancreatitis	0.00197	0.0191	CcSEcCtD
Pramipexole—Rash papular—Hyoscyamine—pancreatitis	0.00197	0.0191	CcSEcCtD
Pramipexole—Arrhythmia supraventricular—Hyoscyamine—pancreatitis	0.0019	0.0184	CcSEcCtD
Pramipexole—Nasal dryness—Hyoscyamine—pancreatitis	0.00186	0.018	CcSEcCtD
Pramipexole—Sinus tachycardia—Hyoscyamine—pancreatitis	0.00182	0.0177	CcSEcCtD
Pramipexole—Hyperreflexia—Hyoscyamine—pancreatitis	0.00159	0.0154	CcSEcCtD
Pramipexole—Loss of libido—Hyoscyamine—pancreatitis	0.00159	0.0154	CcSEcCtD
Pramipexole—Salivary hypersecretion—Propantheline—pancreatitis	0.00139	0.0135	CcSEcCtD
Pramipexole—Balance disorder—Hyoscyamine—pancreatitis	0.00134	0.013	CcSEcCtD
Pramipexole—Accommodation disorder—Hyoscyamine—pancreatitis	0.00128	0.0124	CcSEcCtD
Pramipexole—Visual acuity reduced—Hyoscyamine—pancreatitis	0.00124	0.012	CcSEcCtD
Pramipexole—Blepharitis—Hyoscyamine—pancreatitis	0.0012	0.0116	CcSEcCtD
Pramipexole—Keratitis—Hyoscyamine—pancreatitis	0.00113	0.011	CcSEcCtD
Pramipexole—Supraventricular tachycardia—Hyoscyamine—pancreatitis	0.00112	0.0109	CcSEcCtD
Pramipexole—Thirst—Propantheline—pancreatitis	0.0011	0.0106	CcSEcCtD
Pramipexole—Paranoia—Hyoscyamine—pancreatitis	0.00108	0.0105	CcSEcCtD
Pramipexole—Paralysis—Hyoscyamine—pancreatitis	0.00106	0.0103	CcSEcCtD
Pramipexole—Cyanosis—Hyoscyamine—pancreatitis	0.00104	0.0101	CcSEcCtD
Pramipexole—Laryngitis—Hyoscyamine—pancreatitis	0.00102	0.00989	CcSEcCtD
Pramipexole—Mania—Hyoscyamine—pancreatitis	0.00101	0.0098	CcSEcCtD
Pramipexole—Laryngospasm—Hyoscyamine—pancreatitis	0.000985	0.00954	CcSEcCtD
Pramipexole—Stupor—Hyoscyamine—pancreatitis	0.000985	0.00954	CcSEcCtD
Pramipexole—Ventricular fibrillation—Hyoscyamine—pancreatitis	0.00096	0.0093	CcSEcCtD
Pramipexole—Rash erythematous—Hyoscyamine—pancreatitis	0.00096	0.0093	CcSEcCtD
Pramipexole—Feeling hot—Hyoscyamine—pancreatitis	0.000937	0.00908	CcSEcCtD
Pramipexole—Ageusia—Hyoscyamine—pancreatitis	0.000907	0.00879	CcSEcCtD
Pramipexole—Abdominal distension—Propantheline—pancreatitis	0.000907	0.00879	CcSEcCtD
Pramipexole—Dysphagia—Propantheline—pancreatitis	0.000901	0.00873	CcSEcCtD
Pramipexole—Petechiae—Hyoscyamine—pancreatitis	0.000893	0.00866	CcSEcCtD
Pramipexole—Extrasystoles—Hyoscyamine—pancreatitis	0.000874	0.00847	CcSEcCtD
Pramipexole—Speech disorder—Hyoscyamine—pancreatitis	0.000855	0.00828	CcSEcCtD
Pramipexole—Delirium—Hyoscyamine—pancreatitis	0.000855	0.00828	CcSEcCtD
Pramipexole—Erectile dysfunction—Propantheline—pancreatitis	0.00083	0.00804	CcSEcCtD
Pramipexole—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.000814	0.00789	CcSEcCtD
Pramipexole—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.000814	0.00789	CcSEcCtD
Pramipexole—Drowsiness—Propantheline—pancreatitis	0.000803	0.00779	CcSEcCtD
Pramipexole—Leukocytosis—Hyoscyamine—pancreatitis	0.000782	0.00758	CcSEcCtD
Pramipexole—Dysarthria—Hyoscyamine—pancreatitis	0.000777	0.00753	CcSEcCtD
Pramipexole—Muscle twitching—Hyoscyamine—pancreatitis	0.000749	0.00726	CcSEcCtD
Pramipexole—Respiratory failure—Hyoscyamine—pancreatitis	0.000749	0.00726	CcSEcCtD
Pramipexole—Dermatitis contact—Hyoscyamine—pancreatitis	0.000726	0.00704	CcSEcCtD
Pramipexole—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.00071	0.00688	CcSEcCtD
Pramipexole—Skin exfoliation—Hyoscyamine—pancreatitis	0.000702	0.0068	CcSEcCtD
Pramipexole—Photophobia—Hyoscyamine—pancreatitis	0.00069	0.00669	CcSEcCtD
Pramipexole—Dry eye—Hyoscyamine—pancreatitis	0.000679	0.00658	CcSEcCtD
Pramipexole—Coma—Hyoscyamine—pancreatitis	0.000672	0.00651	CcSEcCtD
Pramipexole—Flushing—Propantheline—pancreatitis	0.000669	0.00649	CcSEcCtD
Pramipexole—Rash maculo-papular—Hyoscyamine—pancreatitis	0.000668	0.00648	CcSEcCtD
Pramipexole—Pulmonary oedema—Hyoscyamine—pancreatitis	0.000654	0.00634	CcSEcCtD
Pramipexole—Hypertonia—Hyoscyamine—pancreatitis	0.000644	0.00625	CcSEcCtD
Pramipexole—Hyperkinesia—Hyoscyamine—pancreatitis	0.000641	0.00621	CcSEcCtD
Pramipexole—Tension—Propantheline—pancreatitis	0.000616	0.00597	CcSEcCtD
Pramipexole—Nervousness—Propantheline—pancreatitis	0.00061	0.00591	CcSEcCtD
Pramipexole—Disorientation—Hyoscyamine—pancreatitis	0.000596	0.00578	CcSEcCtD
Pramipexole—Eczema—Hyoscyamine—pancreatitis	0.000594	0.00576	CcSEcCtD
Pramipexole—Vision blurred—Propantheline—pancreatitis	0.000592	0.00573	CcSEcCtD
Pramipexole—Eye pain—Hyoscyamine—pancreatitis	0.000591	0.00573	CcSEcCtD
Pramipexole—Nasal congestion—Hyoscyamine—pancreatitis	0.000586	0.00568	CcSEcCtD
Pramipexole—Amnesia—Hyoscyamine—pancreatitis	0.000568	0.00551	CcSEcCtD
Pramipexole—Atrial fibrillation—Hyoscyamine—pancreatitis	0.000563	0.00546	CcSEcCtD
Pramipexole—Thirst—Hyoscyamine—pancreatitis	0.000561	0.00543	CcSEcCtD
Pramipexole—Palpitations—Propantheline—pancreatitis	0.000555	0.00538	CcSEcCtD
Pramipexole—Hypoglycaemia—Hyoscyamine—pancreatitis	0.000547	0.0053	CcSEcCtD
Pramipexole—Lethargy—Hyoscyamine—pancreatitis	0.000545	0.00528	CcSEcCtD
Pramipexole—Hyponatraemia—Hyoscyamine—pancreatitis	0.000536	0.00519	CcSEcCtD
Pramipexole—Osteoarthritis—Hyoscyamine—pancreatitis	0.000534	0.00517	CcSEcCtD
Pramipexole—Dry mouth—Propantheline—pancreatitis	0.000523	0.00507	CcSEcCtD
Pramipexole—Psychotic disorder—Hyoscyamine—pancreatitis	0.000521	0.00505	CcSEcCtD
Pramipexole—Confusional state—Propantheline—pancreatitis	0.000517	0.00501	CcSEcCtD
Pramipexole—Irritability—Hyoscyamine—pancreatitis	0.000509	0.00494	CcSEcCtD
Pramipexole—Urinary retention—Hyoscyamine—pancreatitis	0.000507	0.00492	CcSEcCtD
Pramipexole—Cardiac arrest—Hyoscyamine—pancreatitis	0.000507	0.00492	CcSEcCtD
Pramipexole—Ataxia—Hyoscyamine—pancreatitis	0.000502	0.00486	CcSEcCtD
Pramipexole—Tachycardia—Propantheline—pancreatitis	0.0005	0.00485	CcSEcCtD
Pramipexole—Dehydration—Hyoscyamine—pancreatitis	0.000496	0.00481	CcSEcCtD
Pramipexole—Dry skin—Hyoscyamine—pancreatitis	0.000489	0.00474	CcSEcCtD
Pramipexole—Hypokalaemia—Hyoscyamine—pancreatitis	0.000486	0.00471	CcSEcCtD
Pramipexole—Abdominal distension—Hyoscyamine—pancreatitis	0.000464	0.0045	CcSEcCtD
Pramipexole—Insomnia—Propantheline—pancreatitis	0.000463	0.00449	CcSEcCtD
Pramipexole—Dysphagia—Hyoscyamine—pancreatitis	0.000461	0.00447	CcSEcCtD
Pramipexole—Somnolence—Propantheline—pancreatitis	0.000455	0.00441	CcSEcCtD
Pramipexole—Angina pectoris—Hyoscyamine—pancreatitis	0.000449	0.00435	CcSEcCtD
Pramipexole—Constipation—Propantheline—pancreatitis	0.000438	0.00425	CcSEcCtD
Pramipexole—Dysuria—Hyoscyamine—pancreatitis	0.000431	0.00418	CcSEcCtD
Pramipexole—Erectile dysfunction—Hyoscyamine—pancreatitis	0.000425	0.00412	CcSEcCtD
Pramipexole—Feeling abnormal—Propantheline—pancreatitis	0.000422	0.00409	CcSEcCtD
Pramipexole—Hyperglycaemia—Hyoscyamine—pancreatitis	0.000416	0.00403	CcSEcCtD
Pramipexole—Drowsiness—Hyoscyamine—pancreatitis	0.000411	0.00399	CcSEcCtD
Pramipexole—Depression—Hyoscyamine—pancreatitis	0.00041	0.00397	CcSEcCtD
Pramipexole—Urticaria—Propantheline—pancreatitis	0.000407	0.00394	CcSEcCtD
Pramipexole—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.000405	0.00393	CcSEcCtD
Pramipexole—Myocardial infarction—Hyoscyamine—pancreatitis	0.000403	0.00391	CcSEcCtD
Pramipexole—Conjunctivitis—Hyoscyamine—pancreatitis	0.0004	0.00387	CcSEcCtD
Pramipexole—Sweating—Hyoscyamine—pancreatitis	0.000394	0.00382	CcSEcCtD
Pramipexole—Hypersensitivity—Propantheline—pancreatitis	0.000377	0.00366	CcSEcCtD
Pramipexole—Bradycardia—Hyoscyamine—pancreatitis	0.000376	0.00364	CcSEcCtD
Pramipexole—Asthenia—Propantheline—pancreatitis	0.000368	0.00356	CcSEcCtD
Pramipexole—Hallucination—Hyoscyamine—pancreatitis	0.000367	0.00356	CcSEcCtD
Pramipexole—Flushing—Hyoscyamine—pancreatitis	0.000343	0.00332	CcSEcCtD
Pramipexole—Dizziness—Propantheline—pancreatitis	0.000339	0.00328	CcSEcCtD
Pramipexole—Vomiting—Propantheline—pancreatitis	0.000326	0.00316	CcSEcCtD
Pramipexole—Mental disorder—Hyoscyamine—pancreatitis	0.000323	0.00313	CcSEcCtD
Pramipexole—Rash—Propantheline—pancreatitis	0.000323	0.00313	CcSEcCtD
Pramipexole—Dermatitis—Propantheline—pancreatitis	0.000323	0.00313	CcSEcCtD
Pramipexole—Erythema—Hyoscyamine—pancreatitis	0.000321	0.00311	CcSEcCtD
Pramipexole—Headache—Propantheline—pancreatitis	0.000321	0.00311	CcSEcCtD
Pramipexole—Tension—Hyoscyamine—pancreatitis	0.000315	0.00306	CcSEcCtD
Pramipexole—Dysgeusia—Hyoscyamine—pancreatitis	0.000315	0.00305	CcSEcCtD
Pramipexole—Nervousness—Hyoscyamine—pancreatitis	0.000312	0.00303	CcSEcCtD
Pramipexole—Nausea—Propantheline—pancreatitis	0.000304	0.00295	CcSEcCtD
Pramipexole—Vision blurred—Hyoscyamine—pancreatitis	0.000303	0.00294	CcSEcCtD
Pramipexole—Agitation—Hyoscyamine—pancreatitis	0.000295	0.00286	CcSEcCtD
Pramipexole—Vertigo—Hyoscyamine—pancreatitis	0.000289	0.0028	CcSEcCtD
Pramipexole—Syncope—Hyoscyamine—pancreatitis	0.000288	0.00279	CcSEcCtD
Pramipexole—Palpitations—Hyoscyamine—pancreatitis	0.000284	0.00275	CcSEcCtD
Pramipexole—Loss of consciousness—Hyoscyamine—pancreatitis	0.000282	0.00274	CcSEcCtD
Pramipexole—Convulsion—Hyoscyamine—pancreatitis	0.000278	0.0027	CcSEcCtD
Pramipexole—Chest pain—Hyoscyamine—pancreatitis	0.000274	0.00265	CcSEcCtD
Pramipexole—Anxiety—Hyoscyamine—pancreatitis	0.000273	0.00264	CcSEcCtD
Pramipexole—Dry mouth—Hyoscyamine—pancreatitis	0.000268	0.00259	CcSEcCtD
Pramipexole—Confusional state—Hyoscyamine—pancreatitis	0.000264	0.00256	CcSEcCtD
Pramipexole—Oedema—Hyoscyamine—pancreatitis	0.000262	0.00254	CcSEcCtD
Pramipexole—Shock—Hyoscyamine—pancreatitis	0.000258	0.0025	CcSEcCtD
Pramipexole—Tachycardia—Hyoscyamine—pancreatitis	0.000256	0.00248	CcSEcCtD
Pramipexole—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000254	0.00246	CcSEcCtD
Pramipexole—Hypotension—Hyoscyamine—pancreatitis	0.000245	0.00238	CcSEcCtD
Pramipexole—Insomnia—Hyoscyamine—pancreatitis	0.000237	0.0023	CcSEcCtD
Pramipexole—Dyspnoea—Hyoscyamine—pancreatitis	0.000234	0.00227	CcSEcCtD
Pramipexole—Somnolence—Hyoscyamine—pancreatitis	0.000233	0.00226	CcSEcCtD
Pramipexole—Dyspepsia—Hyoscyamine—pancreatitis	0.000231	0.00224	CcSEcCtD
Pramipexole—Fatigue—Hyoscyamine—pancreatitis	0.000226	0.00219	CcSEcCtD
Pramipexole—Pain—Hyoscyamine—pancreatitis	0.000224	0.00217	CcSEcCtD
Pramipexole—Constipation—Hyoscyamine—pancreatitis	0.000224	0.00217	CcSEcCtD
Pramipexole—Feeling abnormal—Hyoscyamine—pancreatitis	0.000216	0.00209	CcSEcCtD
Pramipexole—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000214	0.00208	CcSEcCtD
Pramipexole—Urticaria—Hyoscyamine—pancreatitis	0.000208	0.00202	CcSEcCtD
Pramipexole—Abdominal pain—Hyoscyamine—pancreatitis	0.000207	0.00201	CcSEcCtD
Pramipexole—Body temperature increased—Hyoscyamine—pancreatitis	0.000207	0.00201	CcSEcCtD
Pramipexole—Hypersensitivity—Hyoscyamine—pancreatitis	0.000193	0.00187	CcSEcCtD
Pramipexole—Asthenia—Hyoscyamine—pancreatitis	0.000188	0.00182	CcSEcCtD
Pramipexole—Pruritus—Hyoscyamine—pancreatitis	0.000186	0.0018	CcSEcCtD
Pramipexole—Diarrhoea—Hyoscyamine—pancreatitis	0.000179	0.00174	CcSEcCtD
Pramipexole—Dizziness—Hyoscyamine—pancreatitis	0.000173	0.00168	CcSEcCtD
Pramipexole—Vomiting—Hyoscyamine—pancreatitis	0.000167	0.00162	CcSEcCtD
Pramipexole—Rash—Hyoscyamine—pancreatitis	0.000165	0.0016	CcSEcCtD
Pramipexole—Dermatitis—Hyoscyamine—pancreatitis	0.000165	0.0016	CcSEcCtD
Pramipexole—Headache—Hyoscyamine—pancreatitis	0.000164	0.00159	CcSEcCtD
Pramipexole—Nausea—Hyoscyamine—pancreatitis	0.000156	0.00151	CcSEcCtD
Pramipexole—DRD5—Signaling Pathways—CXCL8—pancreatitis	6.7e-06	9.11e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—LEP—pancreatitis	6.7e-06	9.11e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PDGFA—pancreatitis	6.67e-06	9.08e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—HRAS—pancreatitis	6.65e-06	9.05e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LPL—pancreatitis	6.65e-06	9.04e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—pancreatitis	6.61e-06	9e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—LEP—pancreatitis	6.61e-06	8.99e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KNG1—pancreatitis	6.6e-06	8.99e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—INS—pancreatitis	6.59e-06	8.97e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SPP1—pancreatitis	6.51e-06	8.85e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCL2—pancreatitis	6.49e-06	8.83e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CXCL8—pancreatitis	6.48e-06	8.81e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SPP1—pancreatitis	6.47e-06	8.81e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—INS—pancreatitis	6.46e-06	8.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—LPL—pancreatitis	6.46e-06	8.79e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CXCL8—pancreatitis	6.44e-06	8.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CCL2—pancreatitis	6.44e-06	8.76e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR2A—pancreatitis	6.42e-06	8.73e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CASP3—pancreatitis	6.41e-06	8.72e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—HRAS—pancreatitis	6.41e-06	8.72e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—NRAS—pancreatitis	6.41e-06	8.72e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—pancreatitis	6.37e-06	8.67e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—INS—pancreatitis	6.35e-06	8.65e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCL2—pancreatitis	6.35e-06	8.65e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SPP1—pancreatitis	6.29e-06	8.57e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CXCL8—pancreatitis	6.27e-06	8.53e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CXCL8—pancreatitis	6.26e-06	8.52e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCL2—pancreatitis	6.25e-06	8.51e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR2A—pancreatitis	6.19e-06	8.43e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL5—pancreatitis	6.17e-06	8.39e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	6.16e-06	8.39e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR2A—pancreatitis	6.16e-06	8.38e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—KRAS—pancreatitis	6.12e-06	8.33e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PDGFA—pancreatitis	6.07e-06	8.26e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL5—pancreatitis	6.07e-06	8.26e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—INS—pancreatitis	6.07e-06	8.25e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—NRAS—pancreatitis	6.04e-06	8.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LPL—pancreatitis	6.03e-06	8.21e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—KRAS—pancreatitis	6e-06	8.16e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—pancreatitis	5.99e-06	8.16e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCL2—pancreatitis	5.97e-06	8.12e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PPARG—pancreatitis	5.97e-06	8.12e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—LEP—pancreatitis	5.96e-06	8.12e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—NRAS—pancreatitis	5.96e-06	8.11e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LPL—pancreatitis	5.93e-06	8.08e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—KRAS—pancreatitis	5.87e-06	7.99e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—INS—pancreatitis	5.85e-06	7.96e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PPARG—pancreatitis	5.8e-06	7.9e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—KRAS—pancreatitis	5.78e-06	7.86e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—LEP—pancreatitis	5.76e-06	7.84e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—LEP—pancreatitis	5.73e-06	7.79e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—INS—pancreatitis	5.72e-06	7.78e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SPP1—pancreatitis	5.71e-06	7.77e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—INS—pancreatitis	5.69e-06	7.75e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CXCL8—pancreatitis	5.69e-06	7.74e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—INS—pancreatitis	5.64e-06	7.68e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCL2—pancreatitis	5.63e-06	7.66e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SPP1—pancreatitis	5.62e-06	7.65e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CXCL8—pancreatitis	5.61e-06	7.63e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	5.6e-06	7.61e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LEP—pancreatitis	5.57e-06	7.58e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PPARG—pancreatitis	5.56e-06	7.57e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCL2—pancreatitis	5.55e-06	7.56e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL5—pancreatitis	5.52e-06	7.51e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—KRAS—pancreatitis	5.51e-06	7.5e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MDM2—pancreatitis	5.49e-06	7.47e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—INS—pancreatitis	5.45e-06	7.42e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—pancreatitis	5.44e-06	7.4e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LPL—pancreatitis	5.4e-06	7.35e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—NRAS—pancreatitis	5.38e-06	7.32e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NRAS—pancreatitis	5.37e-06	7.31e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MDM2—pancreatitis	5.37e-06	7.31e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—pancreatitis	5.36e-06	7.3e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MDM2—pancreatitis	5.29e-06	7.19e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—pancreatitis	5.22e-06	7.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—HRAS—pancreatitis	5.21e-06	7.08e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—KRAS—pancreatitis	5.2e-06	7.08e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—NRAS—pancreatitis	5.2e-06	7.07e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—NRAS—pancreatitis	5.17e-06	7.03e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—KRAS—pancreatitis	5.13e-06	6.98e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CXCL8—pancreatitis	5.13e-06	6.98e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SPP1—pancreatitis	5.11e-06	6.96e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—HRAS—pancreatitis	5.1e-06	6.94e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—INS—pancreatitis	5.1e-06	6.93e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCL8—pancreatitis	5.09e-06	6.93e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LEP—pancreatitis	5.05e-06	6.88e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MDM2—pancreatitis	5.05e-06	6.87e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—NRAS—pancreatitis	5.03e-06	6.84e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCL8—pancreatitis	5.02e-06	6.84e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL2—pancreatitis	5.01e-06	6.82e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—pancreatitis	5e-06	6.81e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—pancreatitis	4.99e-06	6.79e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—HRAS—pancreatitis	4.99e-06	6.79e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LEP—pancreatitis	4.97e-06	6.77e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCL8—pancreatitis	4.94e-06	6.73e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—INS—pancreatitis	4.92e-06	6.69e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—HRAS—pancreatitis	4.91e-06	6.68e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—pancreatitis	4.91e-06	6.68e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—INS—pancreatitis	4.89e-06	6.66e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—pancreatitis	4.88e-06	6.64e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—pancreatitis	4.87e-06	6.62e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL2—pancreatitis	4.84e-06	6.59e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL2—pancreatitis	4.81e-06	6.55e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—pancreatitis	4.81e-06	6.54e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—pancreatitis	4.78e-06	6.5e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—INS—pancreatitis	4.76e-06	6.48e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MDM2—pancreatitis	4.76e-06	6.48e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—pancreatitis	4.73e-06	6.44e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL8—pancreatitis	4.72e-06	6.42e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARG—pancreatitis	4.71e-06	6.41e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—pancreatitis	4.7e-06	6.4e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MDM2—pancreatitis	4.7e-06	6.39e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—pancreatitis	4.69e-06	6.39e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—HRAS—pancreatitis	4.69e-06	6.38e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL2—pancreatitis	4.68e-06	6.37e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—KRAS—pancreatitis	4.63e-06	6.3e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—KRAS—pancreatitis	4.62e-06	6.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—INS—pancreatitis	4.62e-06	6.29e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—pancreatitis	4.57e-06	6.21e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—NRAS—pancreatitis	4.56e-06	6.21e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—pancreatitis	4.53e-06	6.16e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—pancreatitis	4.52e-06	6.15e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—NRAS—pancreatitis	4.49e-06	6.11e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—pancreatitis	4.49e-06	6.11e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—KRAS—pancreatitis	4.47e-06	6.09e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL8—pancreatitis	4.45e-06	6.05e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—KRAS—pancreatitis	4.45e-06	6.05e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—HRAS—pancreatitis	4.42e-06	6.02e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL8—pancreatitis	4.39e-06	5.97e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—pancreatitis	4.37e-06	5.95e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—HRAS—pancreatitis	4.36e-06	5.94e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—KRAS—pancreatitis	4.33e-06	5.89e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INS—pancreatitis	4.32e-06	5.88e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—pancreatitis	4.26e-06	5.8e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INS—pancreatitis	4.25e-06	5.78e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL2—pancreatitis	4.25e-06	5.78e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MDM2—pancreatitis	4.24e-06	5.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—pancreatitis	4.24e-06	5.77e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—pancreatitis	4.23e-06	5.76e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—pancreatitis	4.2e-06	5.72e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—pancreatitis	4.18e-06	5.69e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—pancreatitis	4.17e-06	5.68e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NRAS—pancreatitis	4.11e-06	5.6e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MDM2—pancreatitis	4.09e-06	5.57e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	4.08e-06	5.56e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MDM2—pancreatitis	4.07e-06	5.54e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NRAS—pancreatitis	4.03e-06	5.48e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NRAS—pancreatitis	3.96e-06	5.4e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL8—pancreatitis	3.96e-06	5.39e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MDM2—pancreatitis	3.96e-06	5.39e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—HRAS—pancreatitis	3.94e-06	5.36e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HRAS—pancreatitis	3.93e-06	5.35e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—KRAS—pancreatitis	3.93e-06	5.34e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—pancreatitis	3.87e-06	5.26e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—KRAS—pancreatitis	3.86e-06	5.26e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL8—pancreatitis	3.83e-06	5.21e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—pancreatitis	3.82e-06	5.2e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL8—pancreatitis	3.81e-06	5.18e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—pancreatitis	3.8e-06	5.18e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—HRAS—pancreatitis	3.8e-06	5.17e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—pancreatitis	3.79e-06	5.16e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NRAS—pancreatitis	3.78e-06	5.15e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—HRAS—pancreatitis	3.78e-06	5.15e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—pancreatitis	3.77e-06	5.13e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—pancreatitis	3.76e-06	5.12e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—pancreatitis	3.74e-06	5.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—pancreatitis	3.71e-06	5.05e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL8—pancreatitis	3.7e-06	5.04e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—pancreatitis	3.68e-06	5.01e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—HRAS—pancreatitis	3.68e-06	5.01e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—pancreatitis	3.66e-06	4.98e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—pancreatitis	3.64e-06	4.96e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—pancreatitis	3.64e-06	4.95e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—pancreatitis	3.62e-06	4.93e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MDM2—pancreatitis	3.59e-06	4.89e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NRAS—pancreatitis	3.57e-06	4.86e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—pancreatitis	3.54e-06	4.82e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—KRAS—pancreatitis	3.54e-06	4.82e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MDM2—pancreatitis	3.54e-06	4.81e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NRAS—pancreatitis	3.52e-06	4.79e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—pancreatitis	3.52e-06	4.79e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—pancreatitis	3.52e-06	4.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	3.51e-06	4.78e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—KRAS—pancreatitis	3.47e-06	4.72e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—KRAS—pancreatitis	3.41e-06	4.64e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL8—pancreatitis	3.36e-06	4.57e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HRAS—pancreatitis	3.34e-06	4.54e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—pancreatitis	3.32e-06	4.51e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL8—pancreatitis	3.31e-06	4.5e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—HRAS—pancreatitis	3.28e-06	4.47e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—pancreatitis	3.27e-06	4.45e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—KRAS—pancreatitis	3.26e-06	4.43e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MDM2—pancreatitis	3.22e-06	4.38e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—pancreatitis	3.22e-06	4.38e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—pancreatitis	3.19e-06	4.35e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NRAS—pancreatitis	3.18e-06	4.33e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—pancreatitis	3.16e-06	4.31e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—pancreatitis	3.14e-06	4.28e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—KRAS—pancreatitis	3.07e-06	4.18e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NRAS—pancreatitis	3.07e-06	4.18e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NRAS—pancreatitis	3.05e-06	4.16e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—KRAS—pancreatitis	3.03e-06	4.13e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HRAS—pancreatitis	3.01e-06	4.1e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	3.01e-06	4.09e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	2.99e-06	4.07e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NRAS—pancreatitis	2.97e-06	4.04e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—pancreatitis	2.95e-06	4.02e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HRAS—pancreatitis	2.95e-06	4.01e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HRAS—pancreatitis	2.9e-06	3.95e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—pancreatitis	2.88e-06	3.92e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—pancreatitis	2.88e-06	3.92e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—pancreatitis	2.86e-06	3.89e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—pancreatitis	2.85e-06	3.88e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—pancreatitis	2.84e-06	3.86e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—pancreatitis	2.82e-06	3.84e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—pancreatitis	2.78e-06	3.78e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HRAS—pancreatitis	2.77e-06	3.77e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—pancreatitis	2.76e-06	3.76e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KRAS—pancreatitis	2.74e-06	3.72e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NRAS—pancreatitis	2.69e-06	3.67e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NRAS—pancreatitis	2.65e-06	3.61e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—pancreatitis	2.65e-06	3.61e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KRAS—pancreatitis	2.64e-06	3.6e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KRAS—pancreatitis	2.63e-06	3.58e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HRAS—pancreatitis	2.61e-06	3.55e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HRAS—pancreatitis	2.58e-06	3.51e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KRAS—pancreatitis	2.56e-06	3.48e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—pancreatitis	2.5e-06	3.41e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—pancreatitis	2.5e-06	3.4e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—pancreatitis	2.47e-06	3.36e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—pancreatitis	2.46e-06	3.35e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NRAS—pancreatitis	2.41e-06	3.28e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HRAS—pancreatitis	2.33e-06	3.17e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KRAS—pancreatitis	2.32e-06	3.16e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KRAS—pancreatitis	2.28e-06	3.11e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HRAS—pancreatitis	2.25e-06	3.06e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	2.24e-06	3.05e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HRAS—pancreatitis	2.23e-06	3.04e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—pancreatitis	2.23e-06	3.03e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HRAS—pancreatitis	2.17e-06	2.96e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—pancreatitis	2.15e-06	2.92e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—pancreatitis	2.14e-06	2.91e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—pancreatitis	2.08e-06	2.83e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KRAS—pancreatitis	2.08e-06	2.83e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HRAS—pancreatitis	1.97e-06	2.68e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HRAS—pancreatitis	1.94e-06	2.64e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—pancreatitis	1.89e-06	2.57e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—pancreatitis	1.86e-06	2.53e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HRAS—pancreatitis	1.76e-06	2.4e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—pancreatitis	1.69e-06	2.3e-05	CbGpPWpGaD
